Stage II/III Colon Cancer
2 clinical trials · Condition
◉ Watch Stage II/III Colon Cancer
| Record | Firm | Date |
|---|---|---|
| A Screening Study Targeting Tumor-specific Antigens (NCT05158621) | Gritstone bio, Inc. | 2021-12-14 |
Track Stage II/III Colon Cancer automatically
Every clearance here is in the API, with alerts when new ones post.